Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

People Battling Illnesses, Injuries Discuss Personal Experiences At BIO 2000
Mar 22 2000
WASHINGTON, DC (March 22, 2000) People benefiting from innovative biotechnology treatments against such diseases as rheumatoid arthritis, multiple sclerosis...
BIO 2000 Speakers Discuss Human Genome Project, Agricultural Biotech In Developing Nations
Mar 17 2000
WASHINGTON, D.C. (March 17, 2000) Featured speakers at BIO 2000's lunch Wednesday, March 29, will discuss a variety of topics, including the risks and...
Backgrounder On Patenting Gene-Based Inventions
Mar 16 2000
WASHINGTON, DC (March 15, 2000) In response to the statement March 14 by President Bill Clinton and British Prime Minister Tony Blair and subsequent reaction...
BIO 2000 Attracts Record International Contingent
Mar 14 2000
Washington, D.C., (March 14, 2000) -- BIO 2000 in Boston, March 26-30, will include the largest international contingent ever assembled for the annual...
BIO Responds To Clinton, Blair Statement On Gene-Based Health-Care Research
Mar 14 2000
WASHINGTON, DC (March 14, 2000) The Biotechnology Industry Organization (BIO) issued the following response to the statement made today by President Bill...
BIO Testifies In Support Of Gene Therapy Trials
Mar 10 2000
WASHINGTON, D.C. (March 10, 2000) The Biotechnology Industry Organization (BIO) applauded the National Institutes of Health Recombinant DNA Advisory Committee...
Maine Price Controls Will Stifle Biotech Innovation
Mar 8 2000
WASHINGTON, D.C. (March 8, 2000) Nancy Myers, health care policy and reimbursement counsel of the Biotechnology Industry Organization (BIO), issued the...
BIO 2000 Science Presentations Feature Latest Research Breakthroughs
Mar 7 2000
WASHINGTON, D.C. (March 7, 2000) BIO 2000 in Boston, March 26-30, will feature four days of scientific presentations examining the latest research on a...
BIO Response to National Organic Standards
Mar 7 2000
(Dr. Val Giddings, vice president for food and agriculture for BIO, today issued the following statement regarding USDA’s proposed new national organic...
Dry Joins BIO As Director Of Communications
Mar 6 2000
WASHINGTON, D.C. (March 6, 2000) -- Lisa J. Dry has been named Director of Communications for the Biotechnology Industry Organization (BIO). She will assume...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...